Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Zuerblis Kenneth J

SEC-identified person · CIK 1007923 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Stemline Therapeutics INC STML Director filed 2013 - 2020
Savient Pharmaceuticals INC SVNT EVP, Chief Financial Officer filed 2011 - 2012
Immunomedics INC IMMU Director filed 2010 - 2011
Imclone Systems INC/DE IMCL SVP and CFO filed 2008 - 2008
XTL Biopharmaceuticals LTD XTLB Director filed 2008 - 2008

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.